153 related articles for article (PubMed ID: 37954220)
1. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study.
Beydon M; Pinto S; De Rycke Y; Fautrel B; Mariette X; Seror R; Tubach F
Lancet Reg Health Eur; 2023 Dec; 35():100768. PubMed ID: 37954220
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.
Lee H
Yonsei Med J; 2019 Feb; 60(2):223-229. PubMed ID: 30666845
[TBL] [Abstract][Full Text] [Related]
4. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study.
Staples MP; March L; Hill C; Lassere M; Buchbinder R
BMC Rheumatol; 2019; 3():1. PubMed ID: 30886989
[TBL] [Abstract][Full Text] [Related]
5. No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.
Huang WK; Chiou MJ; Kuo CF; Lin YC; Yu KH; See LC
Rheumatol Int; 2014 Oct; 34(10):1379-86. PubMed ID: 24671499
[TBL] [Abstract][Full Text] [Related]
6. Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study.
Cordtz R; Mellemkjær L; Glintborg B; Hetland ML; Madsen OR; Jensen Hansen IM; Dreyer L
Rheumatology (Oxford); 2016 Jun; 55(6):1017-22. PubMed ID: 26912584
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.
Mercer LK; Davies R; Galloway JB; Low A; Lunt M; Dixon WG; Watson KD; Symmons DP; Hyrich KL;
Rheumatology (Oxford); 2013 Jan; 52(1):91-8. PubMed ID: 23238979
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.
Sankila R; Garwicz S; Olsen JH; Döllner H; Hertz H; Kreuger A; Langmark F; Lanning M; Möller T; Tulinius H
J Clin Oncol; 1996 May; 14(5):1442-6. PubMed ID: 8622057
[TBL] [Abstract][Full Text] [Related]
9. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.
Simon TA; Thompson A; Gandhi KK; Hochberg MC; Suissa S
Arthritis Res Ther; 2015 Aug; 17(1):212. PubMed ID: 26271620
[TBL] [Abstract][Full Text] [Related]
10. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.
Smitten AL; Simon TA; Hochberg MC; Suissa S
Arthritis Res Ther; 2008; 10(2):R45. PubMed ID: 18433475
[TBL] [Abstract][Full Text] [Related]
13. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population.
Hashimoto A; Chiba N; Tsuno H; Komiya A; Furukawa H; Matsui T; Nishino J; Tohma S
J Rheumatol; 2015 Apr; 42(4):564-71. PubMed ID: 25593236
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea.
Ko KM; Moon SJ
Korean J Intern Med; 2023 Jan; 38(1):113-124. PubMed ID: 34407599
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
16. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study.
Buchbinder R; Van Doornum S; Staples M; Lassere M; March L
BMC Musculoskelet Disord; 2015 Oct; 16():309. PubMed ID: 26481039
[TBL] [Abstract][Full Text] [Related]
17. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
18. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
Chang SH; Park JK; Lee YJ; Yang JA; Lee EY; Song YW; Lee EB
Arthritis Res Ther; 2014 Aug; 16(4):428. PubMed ID: 25163486
[TBL] [Abstract][Full Text] [Related]
20. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Harigai M; Nanki T; Koike R; Tanaka M; Watanabe-Imai K; Komano Y; Sakai R; Yamazaki H; Koike T; Miyasaka N
Mod Rheumatol; 2016 Sep; 26(5):642-50. PubMed ID: 26873430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
